GOLDMAN SACHS CHAIRMAN AND CEO DAVID SOLOMON TO ADDRESS THE ECONOMIC CLUB OF WASHINGTON DC
For Immediate Release
October 1, 2025 -- Washington, DC American Industrial Acquisition Corporation (AIAC) and Avara Pharmaceuticals shall host their clients, colleagues, and friends at a reception and luncheon program sponsored by the Economic Club of Washington, D.C., featuring David M. Solomon, Chairman of the Board of Directors and Chief Executive Officer of The Goldman Sachs Group, Inc. on October 30, 2025 in Washington, D.C. As one of the world's leading investment banking, securities and investment management firms, Goldman Sachs provides a wide range of financial services to corporations, financial institutions, governments and individuals worldwide.
Mr. Solomon has been recognized as one of the most influential leaders in global finance. At the Economic Club luncheon, Mr. Solomon will share his remarkable personal journey and his unique perspectives on the future of investment banking, capital markets, the domestic and world economy, and international financial trends.
The reception will begin at 10:45 a.m., followed by the program at 11:30 a.m. and lunch at 12:30 p.m., ending promptly at 1:15 p.m.
L. M. Levie, Chairman of AIAC and Avara Pharmaceuticals and Member of the Economic Club of Washington, D.C., stated, "We look forward to welcoming our friends to this significant luncheon program featuring David Solomon of Goldman Sachs. David's visionary leadership has positioned Goldman Sachs at the forefront of innovation in financial services while maintaining the firm's commitment to excellence and client service that has defined the institution for over 150 years. His strategic vision and deep understanding of global markets make him one of the most respected voices in finance today."
About David M. Solomon
David M. Solomon is Chairman and Chief Executive Officer of The Goldman Sachs Group, Inc. He became CEO on October 1, 2018, and Chairman on January 1, 2019. Under his leadership, Goldman Sachs continues to serve as a leading global investment banking, securities and investment management firm.
Prior to becoming Chairman and CEO, David Solomon had nearly 20 years of leadership experience at Goldman Sachs. Previously he was President and Chief Operating Officer, and served as Co-Head of the Investment Banking Division from 2006 to 2016. David was also Global Head of the Financing Group, which includes all capital markets and derivative products for the firm's corporate clients. He joined Goldman Sachs as a partner in 1999.
Before joining the firm, David held leadership roles at The Irving Trust Company, Drexel Burnham Lambert and Bear Stearns and Co.
David is chairman of the Board of Trustees of Hamilton College and serves on the board of The Robin Hood Foundation. He also serves on the Board of Trustees of New York-Presbyterian Hospital and the Paley Center for Media.
Mr. Solomon earned a BS in Political Science from Hamilton College.
For further information, please see:
WWW.GOLDMANSACHS.COM/OUR-FIRM/LEADERSHIP/DAVID-M-SOLOMON
About American Industrial Acquisition Corporation
American Industrial Acquisition Corporation (AIAC) is a diversified industrial group with manufacturing and distribution sites in 24 countries in North America, Europe, Africa, Asia, and Australia-New Zealand. AIAC has acquired and grown non-core subsidiaries and divisions of Boeing, Siemens, Lockheed Martin, Northrop Grumman, Raytheon, Johnson Controls, Merck, Pfizer, Astellas, Visteon, Carlyle, Ahlstrom, Tolko, Groupe Suez, Groupe Rexel, and many other leading multinational corporations.
AIAC companies serve companies and governmental entities worldwide in all major sectors, including aviation, space, defense, automotive, truck, rail, marine, petrochemical, solar, nuclear, food, confectionary, beverage, civil engineering and infrastructure, commercial construction, mining, dredging, disaster relief, education, medical devices, and pharmaceuticals. In addition, AIAC companies are exclusive, authorized distributors of leading branded industrial and consumer products and serve as critical suppliers for the construction of major airports, schools, hospitals, performing arts and sports centers, offices and hotels throughout Southeast Asia, Australia, and New Zealand. AIAC is a leading manufacturer of building, street, and highway signage in Europe, signage and illumination structures in North America, and a distributor of electrical products throughout France.
Of note, AIAC purchased Boeing Canada in 2005 and has produced over 10,000 unique components for every Boeing jet plane ever since, reliably serving Boeing from manufacturing facilities in North America. A leader in ultra-high precision jet engine component manufacturing, AIAC companies produce 2,200 fan blades for each jet engine produced by GE, Pratt & Whitney, Rolls Royce, and Honeywell.
AIAC companies actively support exploration into outer space, manufacturing critical components for launching and propelling spacecraft and satellites. AIAC customers in this sector include NASA, the European Space Agency, SpaceX, Blue Origin, and Boeing. AIAC companies also lead in the design and manufacture of undersea umbilical cables for worldwide oceanographic research.
AIAC companies produce the critical automotive wire and cable for Tesla, GM, Ford, Chrysler-Fiat, Toyota, and Nissan. In connection with its kraft paper manufacturing interests in Canada and the US, AIAC controls and sustainably manages 22 million acres of Manitoba, Canada forestland, an area equivalent in size to the nation of Hungary. AIAC affiliate, Metallwarenfabrik Gemmingen GmbH, located in Germany, designs, manufactures and distributes high performance, emergency portable power generators utilized in global conflict zones and during natural disasters.
About AIAC Philanthropy
AIAC and the AIAC Foundation support a wide range of nonprofit, nonsectarian, bipartisan organizations which promote international conflict resolution, disaster relief, economic development, environmental sustainability, exploration, and the performing arts. The exploration-focused nonprofit organizations which they actively support include the National Geographic Society, the Royal Geographical Society, the American Museum of Natural History and the Hayden Planetarium, the Victoria & Albert Museum, the National Air and Space Museum, the National Space Society, and the United States Space Foundation.
L. M. Levie, Chairman of AIAC, is a Member of the Centennial Society and Legacy Society of the Economic Club of New York and a Member of the Board of Trustees of the Explorers Club.
AIAC's other beneficiaries include the Appeal of the Nobel Peace Laureates Foundation Inc., the Asia Society, the Atlantic Council, the Bill and Melinda Gates Foundation - Gates Philanthropy Partners, the Bretton Woods Committee, the Carnegie Endowment for International Peace, the Carter Center, the Council on Foreign Relations, the Economic Club of New York, the Foreign Policy Association, the Institut Française des Relations Internationales, the International Committee of the Red Cross, the International Crisis Group, the International Rescue Committee, the Japan Society, the JFK School of Government of Harvard University, the Peterson Institute for International Economics, the Richardson Center for Global Engagement, the Royal Institute of International Affairs (Chatham House), the Sierra Club, and the Trilateral Commission.
For further information, please see:
HTTPS://WWW.AIAC.COM/OUR-VALUES
About Avara Pharmaceutical Services
Avara Pharmaceutical Services is a global leader in contract manufacturing for pharmaceutical and biotechnology companies. With campuses in Arecibo, Puerto Rico; Norman, Oklahoma; and Liscate, Italy, Avara serves 40 countries, producing a wide range of critical medications, including oral solid doses and injectable pharmaceuticals.
During the COVID-19 pandemic, Avara played a key role in manufacturing essential treatments. In 2021, Avara Norman produced the active pharmaceutical ingredients for Remdesivir, a leading COVID-19 treatment. Avara Liscate manufactured Nimbex for AbbVie from 2020 to 2022 and Adrenaline for Pfizer from 2020 to 2024, both vital respiratory drugs for COVID-19 patients. Avara's state-of-the-art facilities ensure compliance with global regulatory standards and enable efficient production processes. Committed to sustainability, Avara invests in advanced manufacturing techniques and environmental initiatives. Trusted by clients such as Aspen, AbbVie, Astellas, Bausch & Lomb, Genentech-Roche, Merck, Organon, Pfizer, SK Life, and others, Avara tailors its services to meet unique client needs.
For further information, please see:
About the Economic Club of Washington, D.C.
Established in 1986 as a nonprofit, nonpartisan organization created to strengthen ties among the diverse and growing business community based in metropolitan Washington, D.C., and with the diplomatic community, The Economic Club of Washington, D.C. promotes global awareness of the pivotal role Washington plays in the national and world economies. Its goals are twofold: to provide a prominent forum where eminent global leaders can share their insights about major issues of the day; and to promote a robust peer community for the area's top executives. Today the Economic Club has nearly 1,000 members representing businesses and organizations operating all over the United States and abroad.
Featured speakers in recent years have included the Presidents of the United States, Colombia, and Panama; the Prime Ministers of Finland, Israel and Singapore; a former Prime Minister of Great Britain; Speakers of the U.S. House of Representatives; heads of the Federal Reserve Board; every Secretary of the Treasury since 1986; other Cabinet members and government officials; and leaders of Fortune Global 100 corporations. David M. Rubenstein, Co-Founder and Co-Chairman of the Board of The Carlyle Group, is the current Chairman.
For further information, please see:
Media Contact:
Isabel Carro-Toro, Vice President
American Industrial Acquisition Corporation
+34 689 295 827 (Spain)
+ 1 787 244 3175 (USA)